These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 25462068)

  • 1. CYP2E1 autoantibodies in liver diseases.
    Sutti S; Rigamonti C; Vidali M; Albano E
    Redox Biol; 2014; 3():72-8. PubMed ID: 25462068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: possible role for molecular mimicry.
    Sutti S; Vidali M; Mombello C; Sartori M; Ingelman-Sundberg M; Albano E
    J Hepatol; 2010 Sep; 53(3):431-8. PubMed ID: 20576306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational anti-cytochrome P4502E1 (CYP2E1) auto-antibodies contribute to necro-inflammatory injury in chronic hepatitis C.
    Sutti S; Vidali M; Mombello C; Sartori M; Albano E
    J Viral Hepat; 2010 Oct; 17(10):685-90. PubMed ID: 20738774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and epigenetic factors in autoimmune reactions toward cytochrome P4502E1 in alcoholic liver disease.
    Vidali M; Stewart SF; Rolla R; Daly AK; Chen Y; Mottaran E; Jones DE; Leathart JB; Day CP; Albano E
    Hepatology; 2003 Feb; 37(2):410-9. PubMed ID: 12540792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of auto-antibodies against cytochrome P4502E1 (CYP2E1) in chronic hepatitis C.
    Vidali M; Occhino G; Ivaldi A; Serino R; Moia S; Alchera E; Carini R; Rigamonti C; Sartori M; Albano E
    J Hepatol; 2007 Apr; 46(4):605-12. PubMed ID: 17196701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Shared Cytochrome p4502E1 Epitope Found in Anesthetic Drug-Induced and Viral Hepatitis.
    McCarthy EK; Vakos A; Cottagiri M; Mantilla JJ; Santhanam L; Thomas DL; Amzel LM; Rose NR; Njoku DB
    mSphere; 2018 Oct; 3(5):. PubMed ID: 30305319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
    Manns MP; Obermayer-Straub P
    Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free radical mechanisms in immune reactions associated with alcoholic liver disease.
    Albano E
    Free Radic Biol Med; 2002 Jan; 32(2):110-4. PubMed ID: 11796198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target proteins in human autoimmunity: cytochromes P450 and UDP- glucuronosyltransferases.
    Obermayer-Straub P; Strassburg CP; Manns MP
    Can J Gastroenterol; 2000 May; 14(5):429-39. PubMed ID: 10851284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum autoantibodies against cytochrome P450 2E1 (CYP2E1) predict severity of necroinflammation of recurrent hepatitis C.
    Rigamonti C; Vidali M; Donato MF; Sutti S; Occhino G; Ivaldi A; Arosio E; Agnelli F; Rossi G; Colombo M; Albano E
    Am J Transplant; 2009 Mar; 9(3):601-9. PubMed ID: 19191768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochrome P450 2E1-deficient MRL+/+ mice are less susceptible to trichloroethene-mediated autoimmunity: Involvement of oxidative stress-responsive signaling pathways.
    Wang G; Wakamiya M; Wang J; Ansari GAS; Khan MF
    Free Radic Biol Med; 2019 Nov; 143():324-330. PubMed ID: 31446053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 2E1 is a cell surface autoantigen in halothane hepatitis.
    Eliasson E; Kenna JG
    Mol Pharmacol; 1996 Sep; 50(3):573-82. PubMed ID: 8794896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CYP2E1 immunoglobulin G4 subclass antibodies and complement in pathogenesis of idiosyncratic drug-induced hepatitis.
    Njoku DB; Mellerson JL; Talor MV; Kerr DR; Faraday NR; Outschoorn I; Rose NR
    Clin Vaccine Immunol; 2006 Feb; 13(2):258-65. PubMed ID: 16467335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune disorders of the liver and bile duct.
    Vierling JM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):427-49. PubMed ID: 1512050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of molecular simulation for mapping conformational CYP2E1 epitopes.
    Vidali M; Hidestrand M; Eliasson E; Mottaran E; Reale E; Rolla R; Occhino G; Albano E; Ingelman-Sundberg M
    J Biol Chem; 2004 Dec; 279(49):50949-55. PubMed ID: 15456790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-positive autoimmune responses against CYP2E1 in refrigeration mechanics exposed to halogenated hydrocarbons.
    Gunnare S; Vidali M; Lillienberg L; Ernstgård L; Sjögren B; Hagberg M; Albano E; Johanson G
    Sci Total Environ; 2007 Sep; 383(1-3):90-7. PubMed ID: 17582468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal CYP2E1: A mediator of alcohol-induced gut leakiness.
    Forsyth CB; Voigt RM; Keshavarzian A
    Redox Biol; 2014; 3():40-6. PubMed ID: 25462064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis.
    Weltman MD; Farrell GC; Hall P; Ingelman-Sundberg M; Liddle C
    Hepatology; 1998 Jan; 27(1):128-33. PubMed ID: 9425928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune responses against oxidant stress and acetaldehyde-derived epitopes in human alcohol consumers.
    Viitala K; Makkonen K; Israel Y; Lehtimäki T; Jaakkola O; Koivula T; Blake JE; Niemelä O
    Alcohol Clin Exp Res; 2000 Jul; 24(7):1103-9. PubMed ID: 10924016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.